Dorothy J. Clarke

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Dorothy Clarke
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Dorothy J. Clarke

Form 4 holding General Counsel, Director

Eterna Therapeutics Inc.

Security class
Stock Option (right to buy)
Shares / value
168,521
Estimated value
Report date
01 Jan 2024
Price
Ownership
Direct
Underlying class
Common Stock, par value $0.005 per share
Underlying amount
Form 4 holding Director

Comera Life Sciences Holdings, Inc.

Security class
Stock Option (Right to Purchase
Shares / value
14,200
Estimated value
Report date
07 Nov 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Dorothy J. Clarke

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .